In cases where the power value was <0.7 or the risk for the development of >30% stenosis in CAD patients did not differ significantly from that of CAD patients with <30% stenosis, the results of the adjusted ORs were not considered for the levels of the following: IgG anti-ApoA-I251–262; IgG anti-ApoA-I251–262 HNE; IgG anti-ApoA-I70–83; IgG anti-ApoA-I70–83 HNE; IgM anti-ApoA-I251–262; IgM anti-ApoA-I70–83; and IgM anti-ApoA-I70–83 HNE (Table 3). This evidence concerns the gene CD40LG and coronary artery disorder.